HARNESS THERAPEUTICS LIMITED
Research and experimental development on biotechnology
HARNESS THERAPEUTICS LIMITED
Research and experimental development on biotechnology
Previous Company Names
Contact & Details
Contact
Registered Address
Minerva Building (B250) Babraham Research Campus Cambridge CB22 3AT United Kingdom
Full company profile for HARNESS THERAPEUTICS LIMITED (11532498), an active life sciences and medical technology company based in Cambridge, United Kingdom. Incorporated 22 Aug 2018. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Net Assets, Total Assets & Total Liabilities (2019–2025)
Cash in Bank
£3.60M
Net Assets
-£8.67M
Total Liabilities
£13.71M
Turnover
N/A
Employees
26
Debt Ratio
272%
Financial History
Revenue, profit, EBITDA and key financial figures
2025 Dec Year End | 2024 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
No fundraising or grants recorded
Investors (0)
No investor information available
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Paulo Fontoura | Director | Portuguese | Switzerland | 16 Sept 2024 | Active |
See all 15 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (2)
Dementia Discovery Gp Lp
United Kingdom
- Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent
Takeda Pharmaceutical Company Limited
Japan
- Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent
Piero Carninci
Ceased 4 Aug 2020
Stefano Gustincich
Ceased 4 Aug 2020
Group Structure
Group Structure
Charges
Charges
No charges registered
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 18 Apr 2026 | Accounts | Annual accounts made up to 31 Dec 2025 | |
| 18 Apr 2026 | Accounts | Annual accounts made up to 31 Dec 2025 | |
| 3 Oct 2025 | Resolution | Resolutions | |
| 26 Aug 2025 | Confirmation Statement | Confirmation statement made on 21 Aug 2025 with no updates | |
| 10 Jun 2025 | Officers | Termination of Alan Keith Boyd as director on 5 Jun 2025 |
Annual accounts made up to 31 Dec 2025
Annual accounts made up to 31 Dec 2025
Resolutions
Confirmation statement made on 21 Aug 2025 with no updates
Termination of Alan Keith Boyd as director on 5 Jun 2025
Recent Activity
Latest Activity
Annual accounts made up to 31 Dec 2025
1 months ago on 18 Apr 2026
Annual accounts made up to 31 Dec 2025
1 months ago on 18 Apr 2026
Resolutions
7 months ago on 3 Oct 2025
Confirmation statement made on 21 Aug 2025 with no updates
8 months ago on 26 Aug 2025
Termination of Alan Keith Boyd as director on 5 Jun 2025
11 months ago on 10 Jun 2025